BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36437941)

  • 1. Association between
    Han X; Zheng L; Mu YY; Li HZ; He XF
    Front Genet; 2022; 13():1032110. PubMed ID: 36437941
    [No Abstract]   [Full Text] [Related]  

  • 2. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
    Peng Y; Sheng X; Xue F; Qian Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis.
    Guo L; Tang K; Quan Z; Zhao Z; Jiang D
    DNA Cell Biol; 2014 Jan; 33(1):29-39. PubMed ID: 24283361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Variants of the
    Li X; Cheng J; Dong B; Yu X; Zhao X; Zhou Z
    Genet Test Mol Biomarkers; 2021 Sep; 25(9):600-610. PubMed ID: 34515523
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Association Studies and Meta-Analyses of
    Wang D; Liu L; Zhang C; Lu W; Wu F; He X
    Front Genet; 2022; 13():887415. PubMed ID: 35832187
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of OPG polymorphisms with risk of osteoporotic fractures: A systematic review and meta-analysis.
    Ding J; Zhang C; Guo Y
    Medicine (Baltimore); 2021 Aug; 100(31):e26716. PubMed ID: 34397809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis.
    Luo Y; Hu Z; Hao J; Jiang W; Shen J; Zhao J
    Genet Test Mol Biomarkers; 2014 Mar; 18(3):211-9. PubMed ID: 24410296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.
    Tariq S; Tariq S; Abualhamael SA; Baig M; Malik AA; Shahzad M
    PLoS One; 2023; 18(9):e0291959. PubMed ID: 37751449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women?
    Zajíčková K; Zemanová A; Hill M; Žofková I
    Physiol Res; 2008; 57 Suppl 1():S153-S157. PubMed ID: 18271681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients.
    Yin LL; Jing N; Zhao ZY; Liu XH; Du J; Qin LL; Song JG; Xu Y
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):37-41. PubMed ID: 28121359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2010 Jan; 37(1):227-34. PubMed ID: 19642016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoprotegerin gene polymorphism and therapeutic response to alendronate in postmenopausal women with osteoporosis].
    Wang C; He JW; Qin YJ; Zhang H; Hu WW; Liu YJ; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2958-62. PubMed ID: 20137703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis.
    Wu J; Li X; Gao F; Gao S; Lyu J; Qiang H
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population.
    Zhou J; Zhao Y
    Med Sci Monit; 2016 Nov; 22():4271-4276. PubMed ID: 27828936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between
    Meng H; Huang S; Yang Y; He X; Fei L; Xing Y
    Front Genet; 2021; 12():698590. PubMed ID: 34899823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.
    Li S; Jiang H; Du N
    PLoS One; 2017; 12(12):e0189825. PubMed ID: 29253005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between interleukin-10 -1082A/G polymorphism and risk of ischemic stroke: a meta-analysis.
    Jin J; Li W; Peng L; Chen J; Li R; Wu P; Tan S
    PLoS One; 2014; 9(4):e94631. PubMed ID: 24732312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis.
    Chai J; Cao XL; Lu F
    Front Neurol; 2021; 12():799022. PubMed ID: 35069427
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women - a pilot study.
    Cvijetic S; Grazio S; Kosovic P; Uremovic M; Nemcic T; Bobic J
    Reumatologia; 2016; 54(1):10-3. PubMed ID: 27407270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.